Indeed, BGP-I serum level was considered a surrogate marker in various liver diseases (chronic hepatitis, alcoholic cirrhosis, primary biliary cirrhosis) with comparable validity to established markers such as gamma glutaryl transferase (GGT) and alkaline phosphatase (ALP). Here, CEACAM1 is linked to liver disorder.